Phosphagenics working on topical opioid patch

March 2013
Australian Life Scientist;Mar/Apr2013, Vol. 10 Issue 2, p6
The article informs that Phosphagenics Ltd. has included an oxycodone-based patch designed for local pain relief in its pain patch portfolio and is also planning to start clinical trials of a similar version of the patch in the third quarter.


Related Articles

  • POSITIVE RESULTS FROM PHASE 1B OF OXYCODONE PATCH.  // Worldwide Biotech;Mar2010, Vol. 22 Issue 3, p1 

    The article reports on the positive results of the Phase 1B clinical study conducted by Phosphagenics Ltd. using its Targeted Penetration Matrix (TPMâ„¢) for the transdermal delivery of oxycodone. The trial has successfully demonstrated that daily application of a TPMâ„¢-oxycodone patch...

  • R&D Update.  // PharmaWatch: CNS;Nov2007, Vol. 6 Issue 11, p10 

    The article offers news briefs related to pharmaceutical industry worldwide in 2007. Adlea is a long-acting, non-opiate analgesic drug which designed for weeks to months pain relief in single local dose during the surgical procedure. Australian company Phosphagenics has received approval to...

  • Monetising a platform technology. Ogru, Esra // Australasian Biotechnology;Oct2011, Vol. 21 Issue 3, p30 

    This sector is acutely aware of the squeeze on Australian companies in raising ongoing capital. Phosphagenics is implementing a range of strategies to reduce the need to return to the market for capital. Phosphagenics' primary goal is to develop a transdermal oxycodone patch. A successfully...

  • CLINICAL TRIALS NEWS.  // Applied Clinical Trials;Jun2007, Vol. 16 Issue 6, p30 

    The article offers news briefs related to clinical trials. Paris, France-based NicOx SA has begun its second Phase III naproxcinod trial to verify the effectiveness of the drug. Sydney, New South Wales-based Alchemia Lid. has completed its Phase II study comparing its product HyCAMP with...

  • TPM/OXYCODONE PATCH TRIAL RECEIVES ETHICS APPROVAL.  // Biotech Business;Jan2015, Vol. 28 Issue 1, p2 

    The article reports that biotechnology company Phosphagenics Ltd. has earned ethics approval for the commencement of proof of concept Phase 2 trial in Australia for its TPM/Oxycodone patch. Topics discussed include the trial's goal of determining the effectiveness of the patch for lessening the...

  • CLINIC ROUNDUP.  // BioWorld Today;11/6/2008, Vol. 19 Issue 217, p6 

    This section offers news briefs related to the biotechnology industries in the U.S. ConjuChem Biotechnologies Inc. completed Phase II trial of its PC-DAC:Exendin-4. Mesoblast Ltd. started Phase I/II trials of its allogeneic mesenchymal precursor cells in patients diagnosed with hematologic...

  • TPM REACHES PHASE 2 OF ACNE TREATMENT TRIAL.  // Worldwide Biotech;Jun2014, Vol. 26 Issue 6, p1 

    The article reports that Australian drug delivery technology firm Phosphagenics Ltd. finished enrollment for its midstage study of its enhanced treatment for acne vulgaris. Topics covered include the topical acne drug tretinoin formulated with the company's proprietary transdermal delivery...

  • Pharma: Clinic Roundup.  // BioWorld Today;3/26/2013, Vol. 24 Issue 59, p5 

    The article reports that Australian firm Phosphagenics Ltd. successfully completed the Phase I trial of its oxymorphone patch.

  • Tissue welding tonsillectomy provides an enhanced recovery compared to that after monopolar electrocautery technique in adults: a prospective randomized clinical trial. Silvola, Juha; Salonen, Aarre; Nieminen, Jouko; Kokki, Hannu // European Archives of Oto-Rhino-Laryngology;Feb2011, Vol. 268 Issue 2, p255 

    We have compared tonsillectomy (TE) with tissue welding (TW) technology using a specially designed forceps versus conventional monopolar electrocautery to evaluate whether this new technology may improve recovery after TE. This was a single-blind, randomized clinical trial with two parallel...


Read the Article


Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics